Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
http://www.merck.com/finance/annualreport/ar2003/product_review/ Annual Report 2003 Chairman's message Financial highlights Management Product review Research pipeline Selected licensing agreements Financial section Board of Directors Corporate information - Merck's commitment: novel medicines that make a difference click photos Product review 1.prtitle { font-size : 12px; padding-left : 9px; padding-right : 2px; padding-bottom : 12px; width:...
Merck News Item launch of ZETIA in mid-November 2002, according to IMS Health.A- ZETIA currently accounts for more than 5 percent of new prescriptions in the cholesterol-lowering class and is now reimbursed for nearly 90 percent of all patients in managed care plans across the United States.A- To date, EZETROL has been launched in more than 40 countries outside of the United States.A-...
Product review Products 1 Aggrastat ® (tirofiban hydrochloride) •-In combination with heparin for treatment of acute coronary syndrome Arcoxia ® (etoricoxib) 2 •-Osteoarthritis •-Rheumatoid arthritis (in adults) •-Acute pain •-Chronic pain •-Dysmenorrhea (menstrual pain) •-Acute gouty arthritis Cancidas ® (caspofungin acetate) •...
BioPortfolio Limited Datamonitor Market and Sales Reports [ Home ] - [ Up ] - [ Catalog ] - [ Info ] - [ Search ] - [ View Basket ] - [ Checkout ] - [ Send email ] - BioPortfolio accept VISA, MASTERCARD and AMEX Bioportfolio - - Datamonitor Market and Sales Reports Psoriasis - Biologics Impact Treatment Regimes Across the Globe Psoriasis is a non-life threatening but highly debilitating disease that currently has no cure.Zetia and...
Advances in the Treatment of Cardiovascular Diseases - - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
author: BioPortfolio - Knowledge Management, Market Analysis and Market Research
Advances in the Treatment of Cardiovascular Diseases - - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
author: BioPortfolio - Knowledge Management, Market Analysis and Market Research
Table of Contents Neuroserpin as a candidate neuroprotective in the treatment of stroke Prourokinase variants as improved thrombolytics The therapeutic opportunities of targeting MCP-1 P2 receptors: new potential players in atherosclerosis FR183998 inhibits Na+/H+ exchange and IL-8 accumulation following cardiac ischemia CB1 antagonists reduce survival rates following experimental myocardial...
BioPortfolio Limited 247 Prescribing of Advicor versus two separate pills in the US 248 Statin + bile acid sequestrant combination 249 Colesevelam is better tolerated than older bile acid sequestrants 250 Statin + fish oil derivative combination 252 Statin + ezetimibe combination 254 Clinical trial data for simvastatin-ezetimibe combination 255 Ezetimibe combined with atorvastatin, lovastatin and...
Merck financials_comp.qxd Research Pipeline Preclinical Diabetes Atherosclerosis Parkinson's disease Pain Anxiety Osteoporosis Cancer Rheumatoid arthritis Glaucoma Antibacterial Vaccines Phase I Diabetes c- 3347 Obesity c- 2624, c- 5093 Atherosclerosis c- 8834 Alzheimer's disease c- 7617, c- 9138 Multiple Sclerosis c- 6448 Pain c- 1246 Psychiatric disease c- 9054 Respiratory disease c- 3193 Rheumatoid...
http://www.fda.gov/cder/orange/appendix_a.txt 4, ACETAMINOPHEN TYLENOL W/ CODEINE, ACETAMINOPHEN TYLENOL, ACETAMINOPHEN (OTC) TYLOX, ACETAMINOPHEN TYLOX-325, ACETAMINOPHEN TYMTRAN, CERULETIDE DIETHYLAMINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE TZ-3, TIOCONAZOLE (OTC) ** U ** U-CORT, HYDROCORTISONE ACETATE U-GENCIN, GENTAMICIN SULFATE UCEPHAN, SODIUM BENZOATE ULO, CHLOPHEDIANOL HYDROCHLORIDE ULTANE, SEVOFLURANE ULTIVA,...
Product review Products 1 Aggrastat ® (tirofiban hydrochloride) •- ;In combination with heparin for treatment of acute coronary syndrome Arcoxia ® (etoricoxib) 2 •-Osteoarthritis •-Rheumatoid arthritis (in adults) •-Acute pain •-Chronic pain •-Dysmenorrhea (menstrual pain) •-Acute gouty arthritis Cancidas ® (caspofungin acetate) •...
Merck News Item - - - - Merck's Ability to Deliver Breakthrough Medicines Provides Opportunities for Significant Growth Over the Long Term Merck Expects to File or Launch 11 New Medicines and Vaccines Between 2002-2006 Regulatory Filings Planned in 2002 for Allergic Rhinitis Indication for Singulair and for Ezetimibe (Zetia), Filing Planned in 2003 for Zetia/Zocor Combination Tablet...
Merck News Item ARCOXIA and ZETIA Fuel Pipeline ARCOXIA and ZETIA are two investigational medicines currently under regulatory review for approval in many countries of the worldEzetimibe will be marketed as EZETROL in GermanyZETIA
Merck News Item a€œIn addition, 10 mg of ZETIA, co-administered with low doses of a statin, provided significant reductions in LDL cholesterol equal to or more than the LDL cholesterol reduction achieved with the highest dose of all statins tested.a€ ZETIA demonstrated excellent safety and tolerability profile in clinical studies ZETIA has been evaluated for...
CDER 2002 Report to the Nation; Drug Review Food and Drug Administration • Center for Drug Evaluation and Research About CDER - Report Search CDER Report to the Nation: 2002 Table of Contents Adobe Acrobat version of this document 1 Drug Review Index Mission Highlights New Drug Review List of priority new drugs List of new molecular entities List of orphan new drugs New Drug Review Statistics Priority new drug statistics...
author: OLIVERN
NMEs Approved in CY 2002 NMEs Approved in Calendar Year 2002 - NDA Number Generic Name Trade Name Dosage Form Applicant *Classification Approval Date 21-232 Nitisinone Orfadin Capsule Swedish Orphan -- 1PV 01-18-2002 21-286 Olmesartan Medoxomil Benicar Tablet Sankyo- 1S 04-25-2002 21-344 Fulvestrant Faslodex Injection AstraZeneca 1S 04-25-2002 21-272 Treprostinil Sodium Remodulin Injection United...
author: Susan Daugherty
Prescription and OTC Drug Product List 10/2002 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -A- AA ABLE 325MG;7.5MG N40464 001 OCT 23, 2002 OCT NEWA -A- AA 325MG;10MG N40464 002 OCT 23, 2002 OCT NEWA -A- AA 650MG;10MG N40476 001 OCT 23, 2002 OCT NEWA -A- AA 750MG;7.5MG N40469 001 OCT 25, 2002 OCT NEWA -A- AA MALLINCKRODT 750MG...
C:\Documents and Settings\kochw\Desktop\NDA21445\LTR2LBL102502.doc ZETIA TM (EZETIMIBE) TABLETS DESCRIPTION ZETIA (ezetimibe) is in a class of lipid- lowering compounds that selectively inhibits the intestinal absorption of cholesterol and related phytosterolsEzetimibe has a mechanism of action that differs from those of other classes of cholesterol- reducing compounds (HMG- CoA reductase inhibitors, bile acid...
author: William Koch
C:\Documents and Settings\kochw\Desktop\NDA21445\LTR2LBL102502.doc page 13
author: William Koch
C:\Documents and Settings\kochw\Desktop\NDA21445\LTR2LBL102502.doc page 4
author: William Koch
C:\Documents and Settings\kochw\Desktop\NDA21445\LTR2LBL102502.doc page 3
author: William Koch
C:\Documents and Settings\kochw\Desktop\NDA21445\LTR2LBL102502.doc page 2
author: William Koch
C:\Documents and Settings\kochw\Desktop\NDA21445\LTR2LBL102502.doc page 1
author: William Koch
